Sunday, 27th of March 2011 |
EMERGING AND TRANSITIONING COUNTRIES’ ROLE IN GLOBAL HEALTH
JENNIFER PRAH RUGER, Ph.D.* AND NORA Y. NG, Ph.D.**
* Associate Professor at Yale University at the Schools of Public Health, Medicine, and
Graduate School of Arts and Sciences and Adjunct faculty at the Law School. A previous
version of this paper, entitled “Public Health and Emerging Risks: Emerging Countries’
Responsibility and International Cooperation,” was presented at the High Level Workshop on
Development Assistance, 7-8 March 2007, European Investment Bank, Luxembourg. Thanks
go to participants at that meeting for their comments and to Betsy Rogers for her editing
assistance. This research was supported, in part, by the Institute for Sustainable Development
and International Relations and the Whitney and Betty MacMillan Center for International and
Area Studies.
** Research assistant to Professor Ruger.
Introduction below; full text is at http://law.slu.edu/healthlaw/journal/archives/Ruger_and_Ng_Article.pdf
I. INTRODUCTION
Global health scholarship has failed to adequately consider the “BRIC”
cluster of nations—Brazil, Russia, India and China—particularly in the
aggregate. An article search with the keywords “BRIC” and “public health”
yields just one publication. But these countries have a unique role to play in
the global health enterprise by addressing global health problems as they
build their own health systems and help developing countries improve their
populations’ health. Moreover, the BRIC nations are becoming increasingly
important components of the global health architecture, individually as
nations and collectively as a nexus of influence. In June 2009, the countries
held the first-ever BRIC summit in Yekaterinburg, Russia, debuting as a
policy consultation and coordination group.1
What these countries collectively have to offer in the quest to improve
global health merits attention. This article focuses on the role of emerging
and transitioning countries as actors in (1) providing financial assistance to
lower-income countries; (2) supplying medical goods and services to the
developing world; (3) giving technical assistance; (4) improving access to
medicines and intellectual property; (5) modeling effective health-sector
framework-building to less developed countries; (6) delivering object lessons
learned from the health and development process; (7) helping lower-income
countries grow their economies and reduce poverty; (8) taking a significant
role in global health governance; and (9) bolstering the link between health
and foreign policy. For all their growing power and potential, however, they
are still emerging and transforming countries with their own daunting and
persisting health challenges that require continuing assistance from the
global health community.
1. Tony Halpin, Brazil, Russia, India and China Form Bloc to Challenge U.S. Global
Dominance, TIMES, June 17, 2009, at 33.
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
40950741 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |